Mayo, Settie Ainah M.
HRN: 11-00-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
CEFTRIAXONE 1G (VIAL)
06/02/2022
06/08/2022
IV
1g
Q12
T/c Meningitis
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes